Launching Rare Disease Drug During COVID Is Challenging but Possible

October 11, 2021

Launching Rare Disease Drug During COVID Is Challenging but Possible Launching on orphan drug in and of itself can be a challenge. But bringing one to market during a pandemic poses a whole additional set of challenges. In 2020, pharma companies accustomed to in-person meetings suddenly found themselves faced with lockdowns not only in the U.S. but around the world. Some firms chose to delay bringing their drugs to market, while others needed to move quickly to modify their launch strategies.

Read the source article at Welcome
2021-10-07 17:34:58

Share This Story!